Paving the way to personalized medicine: Production of some theragnostic radionuclides at Brookhaven National Laboratory

Radiochimica Acta

Volumn 99, Issue 10, 2011, Pages 635-640

  Srivastava, S C ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Copper 67; Radionuclide pairs; Radionuclide therapy; Scandium 47; Theragnostic radionuclides; Tin 117m; Yttrium 86

Indexed keywords

EID: 80053189717     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2011.1882     Document Type: Article

References (35)

1. Srivastava, S. C. (Ed.): Radiolabeled Monoclonal Antibodies for Imaging and Therapy. New York, Plenum Press (1988), 876 pp.
2. Mausner, L. F., Srivastava, S. C: Selection of radionuclides for radioimmunotherapy. Med. Phys. 20, 503-509 (1993).
3. Srivastava, S. C: Criteria for the selection of radionuclides for targeting nuclear antigens for cancer radioimmunotherapy. Cancer Biother. Radiopharm. 11, 43-50 (1996). (Pubitemid 26155585)
4. Mausner, L. F., Kolsky, K. L., Joshi, V., Srivastava, S. C: Radionuclide development at BNL for nuclear medicine therapy. Appl. Radiat. Isot. 49, 285-294 (1998). (Pubitemid 28101655)
5. Srivastava, S. C., Dadachova, E.: Recent advances in radionuclide therapy. Semin. Nucl. Med. 31, 330-341 (2001). (Pubitemid 33027511)
6. Srivastava, S. C: Treatment of bone and joint pain with electron emitting radiopharmaceuticals. Indian J. Nucl. Med. 19, 89-97 (2004).
7. Srivastava, S. C: The role of electron-emitting radiopharmaceuticals in the palliative treatment of metastatic bone pain and for radiosynovectomy: applications of conversion electron emitter tin-117m. Brazil. Arch. Biol. Technol. 50, 49-62 (2007).
8. Srivastava, S. C: Theragnostic radiometals: getting closer to personalized medicine. In: Technetium and Other Radiometals in Chemistry and Nuclear Medicine. (Mazzi, U., et al, eds.) SG Editoriali, Padova, Italy (2010), pp. 553-568.
9. Herzog, H., Rösch, F., Stöcklin, G., Lueders, C., Qaim, S. M., Feinendegen, L. E.: Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics. J. Nucl. Med. 34, 2222-2226 (1993). (Pubitemid 24002971)
10. 3He, xn)-processes. Radiochim. Acta 61, 1 (1993).
11. 86Y for nuclear medical application. Appl. Radiat. Isot. 44, 671 (1993).
12. Srivastava, S. C: Radionuclide therapy with high-LET electron emitters: Therapeutic applications of conversion electron emitter tin-117m. In: Technetium, Rhenium, and Other Metals in Chemistry and Nuclear Medicine. (Mazzi, U., ed.) SG Editoriali, Padova, Italy (2006), pp. 553-568.
13. Ermolaev, S. V., Zhuikov, B. L., Kokhanyuk, V. M., Togaeva, N. R., Khamianov, S. V., Srivastava, S. C: Production of no-carrieradded Tin-117m from proton irradiated antimony. J. Radioanal. Chem. 280, 319-324 (2009).
14. 64Cu at a small cyclotron. Appl. Radiat. Isot. 44, 575-580 (1993). (Pubitemid 23069177)
15. 64Cu reaction and dual ion-exchange column chromatography. Radiochim. Acta 95, 75-80 (2007).
16. 86Y for PET imaging. Appl. Radiat. Isot. 67, 7-10 (2009).
17. Medvedev, D., Mausner, L. F., Srivastava, S. C: Irradiation of strontium chloride targets at proton energies above 35 MeV to produce PET radioisotope Y-86. Radiochim. Acta 99, doi: 10.1524/ract.2011.1880 (2011).
18. 124I at a small cyclotron. Appl. Radiat. Isot. 46, 255-259 (1995).
19. 120gI at a small-sized cyclotron. Appl. Radiat. Isot. 58, 69-78 (2003). (Pubitemid 35453949)
20. 3He-and α-particle induced reactions on antimony isotopes with special relevance to the production of iodine-124. Appl. Radiat. Isot. 69, 94-104 (2001).
21. Qaim, S. M.: Development of novel positron emitters for medical applications: nuclear and radiochemical aspects. Radiochim. Acta 99, doi: 10.1524/ract.2011.1870 (2011).
22. Huclier-Markai, S., Sabatie, A., Kubicek, V., Paris, M., Vidand, C., Hermann, P., Cutler, C. S.: Chemical and biological evaluation of scandium (III)-polyamino-polycarboxylate complexes as potential PET agent and radiopharmaceutical. Radiochim. Acta 99, doi: 10.1524/ract.2011.1869 (2011).
23. Meinken, G. E., Kurczak, S., Mausner, L. F., Kolsky, K. L., Srivastava, S. C: Production of high specific activity Ge-68 at Brookhaven National Laboratory. J. Radioanal. Nucl. Chem. 263, 553-557 (2005). (Pubitemid 40521461)
24. Mausner, L. F., Kolsky, K. L., Mease, R. C., Chinol, M., Meinken, G. E., Straub, R. F., Pietrelli, L., Steplewski, Z., Srivastava, S. C: Production and evaluation of Sc-47 for radioimmunotherapy. J. Label. Compds. Radiopharm. 32, 388-390 (1993).
25. Kolsky, K. L., Joshi, V., Mausner, L. F., Srivastava, S. C: Radiochemical purification of no-carrier-added Scandium-47 for radioimmunotherapy. Appl. Radiat. Isot. 49, 1541-1549 (1998). (Pubitemid 28383968)
26. 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study. Anticancer Res. 18, 2779-2788 (1998). (Pubitemid 28388837)
27. 67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma. J. Nucl. Med. 40, 302-310 (1999). (Pubitemid 29077094)
28. Mirzadeh, S., Mausner, L. F., Srivastava, S. C: Production of nocarrier-added Cu-67. Appl. Radiat. Isot. 37, 29-36 (1986).
29. 67Cu. Radiochim. Acta 90, 309-313 (2002).
30. Krishnamurthy, G. T., Swailem, F. M., Srivastava, S. C., Atkins, H. L., Simpson, L. J. Walsh, T. K., Ahmann, F. R., Meinken, G. E., Shah, J. H.: Tin-117m (4+) DTPA: pharmacokinetics and imaging characteristics in patients with metastatic bone pain. J. Nucl. Med. 38, 230-237 (1997). (Pubitemid 27061601)
31. Srivastava, S. C., Atkins, H. L., Krishnamurthy, G. T., Zanzi, I., Silberstein, E., Meinken, G., Swailem, F., Mausner, L. F., D'Allessandro, T., Cabahug, C. J., Lau, Y., Park, T., Madajewicz.: Treatment of metastatic bone pain with tin-117m (4+) DTPA: a phase II clinical study. Clin. Cancer Res. 4, 61-68 (1998). (Pubitemid 28062878)
32. Li, J., Mueller, D. W., Pendyala, L., Gonzales, G., Adzic, R., Hou, D., Srivastava, S. C., King, S. B., Robinson, K. A., Chronos, N. F.: Acute tin-117m therapy reduces inflammation in atherosclerotic rabbit model, J. Amer. College Cardiolgy, Intervention, to be published (2011).
33. Bishayee, S., Rao, D. V., Srivastava, S. C., Bouchet, L. G., Bolch, W. E., Howell, R. G: Marrow-sparing effects of Sn-117m (4+) DTPA for radionuclide therapy of cancer in bone. J. Nucl. Med. 41, 2043-2050 (2000). (Pubitemid 32038695)
34. Swailem, F. M., Krishnamurthy, G. T., Srivastava, S. C., Aguirre, M. L., Ellerson, D. L., Walsh, T. K., Simpson, L.: In vivo tissue uptake and retention of Sn-117m (4+) DTPA in a human subject with metastatic bone pain and in normal mice. Nucl. Med. Biol. 25, 279-287 (1998). (Pubitemid 28172457)
35. 117mSn. Int. J. Appl. Radiat. Isot. 35, 645-650 (1984). (Pubitemid 14069443)